Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Procyte

Executive Summary

Company receives an unsolicited proposal from Scherer Healthcare and Derma Sciences to combine in a three-way merger in which Procyte shareholders would receive shares in the combined company, Kirkland, Wash.-based Procyte reports. Procyte says the "highly conditional" proposal offers one share of Scherer common stock in exchange for 3.4 shares of Procyte common stock, and one share of Scherer common stock for 4.1 shares of Derma Sciences common stock. Scherer and Derma have purchased 640,550 shares, or 5% of Procyte common stock, which makes the partnership the largest shareholder, the companies say. Scherer and Derma have requested a response from Procyte by Dec. 15
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS025456

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel